APA

Law A. V., Pathak D. S., Segraves A. M., Weinstein C. R. & Arneson W. H. (19960417). Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. : Clinical therapeutics.

Chicago

Law A V, Pathak D S, Segraves A M, Weinstein C R and Arneson W H. 19960417. Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. : Clinical therapeutics.

Harvard

Law A. V., Pathak D. S., Segraves A. M., Weinstein C. R. and Arneson W. H. (19960417). Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. : Clinical therapeutics.

MLA

Law A V, Pathak D S, Segraves A M, Weinstein C R and Arneson W H. Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. : Clinical therapeutics. 19960417.